Techne Corp (NASDAQ:TECH)

fools news letter recommended selling

Minneapolis company so it must be good. Time to buy.

Sales have grown steadily while the cost of sales has decreased. Revenue and earnings have also increased over the past two years.

I have previously stated that I subscribe to MF to get their fundamental research information. Also if anyone wants to see my Technical approach on any of my listed stocks, visit manageyourowntrades.com. This and all the stocks I currently own are listed on the above web site.

Great new playground, TECH is well established and expert in field, governance excellent, even has a dividend to go with growth potential.

Demographics...just look at all those 'Doctor' shows on TV! We are definitely getting older as a society due to the population demographics and longer life span, but all these shows, and debate about healthcare, have everyone much more focused on healthcare.
TECH is a great company to capitalize on both, given its product breadth and solid financials.

For all the reasons Tom gardner said plus I think there is going to be a boom in colleges and universities and a push by government which means...more research....more business for TECH

biotech growth for 50 years

Ok!

Like their services and product line. Good market.

wide moat, profitable,

Biotech is growing and will accelerate. TECH helps others do what they do.

SA pick and moat

I like R&D in biotech. This is great exposure to the sector. Research/Development (and global presence) = Innovations/Patents/Profits - it just makes sense...LONG

Two insider purchases at just under the current price. Fundamentals back it up. No, I don't care that it once again has bad technicals.

low debt, high free cash flow, great long term growth, strong competitive position

Techne Corp. (TECH) is a manufacturer of biotechnology products. The company has consistently grown earnings year each year since 1989. Currently, its latest 12 month's earnings are $2.82 and fiscal 2009 (June 30, 2009) should surpass last year's $2.64 by a substantial amount.

Recently, TECH instituted a dividend which currently yields 1.1% on its $46.98 price.
EVO = 10.00 and QVT Rating is a very high 9.91

No debt, increasing guidances, and < 50 day moving avg.

ibd